Use of Sedating Drugs and Neuromuscular Blocking Agents in Patients Requiring Mechanical Ventilation for Respiratory Failure: A National Survey

JAMA: The Journal of the American Medical Association

Volumn 266, Issue 20, 1991, Pages 2870-2875

  Hansen Flaschen, John H ^a   Brazinsky, Shari ^a   Basile, Carol ^a   Lanken, Paul N ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPNOTIC SEDATIVE AGENT; NEUROMUSCULAR BLOCKING AGENT; ATRACURIUM BESILATE; DIAZEPAM; FENTANYL; HALOPERIDOL; LORAZEPAM; MIDAZOLAM; MORPHINE SULFATE; OXAZEPAM; PANCURONIUM BROMIDE; PETHIDINE; TRIAZOLAM; VECURONIUM;

ARTICLE; ARTIFICIAL VENTILATION; DRUG UTILIZATION; EMERGENCY; HUMAN; INTENSIVE CARE UNIT; QUESTIONNAIRE; RESPIRATORY FAILURE; TEACHING HOSPITAL; UNITED STATES; DRUG USE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

DRUG UTILIZATION; EMERGENCIES; HOSPITALS, TEACHING; HUMAN; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; NEUROMUSCULAR BLOCKING AGENTS; QUESTIONNAIRES; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; UNITED STATES;

EID: 0025919720     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1991.03470200082040     Document Type: Article

References (34)

1. Harris CE, Grounds RM, Murray AM, Lumley J, Rosston D, Morgan M. Propofol for long-term sedation in the intensive care unit. Anaesthesia. 1985;45:366-372.
2. Crippen DW. The role of sedation in the ICU patient with pain and agitation. Crit Care Clin. 1990;6:369-392.
3. Figge H, Huang V, Kaul AF, Demling RH. The pharmacotherapy of the behavioral manifestations of the ICU syndrome. J Crit Care. 1987;2:199-205.
4. Hansen-Flaschen JH. The agitated patient in respiratory failure. In: Fishman AP, ed. Pulmonary Diseases and Disorders: Update. New York, NY: McGraw-Hill International Book Co; 1991:383-400.
5. Gramsted L, Lilleaasen P. Neuromuscular blocking effects of atracurium, vecuronium, and pancuronium during bolus and infusion administration. Br J Anaesth. 1985;57:1052-1059.
6. Wadon AJ, Dogra S, Anand S. Atracurium infusion in the intensive care unit. Br J Anaesth. 1986;58(suppl 1):64S-67S.
7. Farina ML, Levati A, Tognoni G. A multicenter study of drug utilization. Intensive Care Med. 1981;7:125-131.
8. Bion JF, Ledingham IM. Sedation in intensive care: a postal survey. Intensive Care Med. 1987;13:215-216.
9. Merriman HM. The techniques used to sedate ventilated patients: a survey of methods used in 34 ICUs in Great Britain. Intensive Care Med. 1981;7:217-224.
10. Miller-Jones CMH, Williams JH. Sedation for ventilation: a retrospective study of 50 patients. Anaesthesia. 1980;35:1104-1107.
11. American Thoracic Society. Training programs in adult respiratory disease. Am Rev Respir Dis. 1990;142:955-982.
12. American Hospital Association Guide to the Health Care Field. Chicago, Ill: American Hospital Association; 1989.
13. Rogers RM, Petty TL, Hudson LD, Briggs DD. Critical care medicine certification and pulmonary disease trainees. Am Rev Respir Dis. 1990;142:495-496.
14. Kendall MJ, Clarke SW. Prolonged coma after tetanus. BMJ. 1972;2:354-355.
15. Martyn J. Clinical pharmacology and drug therapy in the burned patient. Anesthesiology. 1986;65:67-75.
16. Stevens DS, Edwards WT. Management of pain in the critically ill. J Intensive Care Med. 1990;5:258-291.
17. Veselis RA. Intravenous narcotics in the ICU. Crit Care Clin. 1990;6:295-313.
18. Menza MA, Murray GB, Holmes VF, Rafuls WA. Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines. Heart Lung. 1988;17:238-241.
19. Aitkenhead AR, Pepperman ML, Willatts SM, et al. Comparison of propofol and midazolam for sedation in critically ill patients. Lancet. 1989;2:704-709.
20. Parker CJ, Jones JE, Hunter JM. Disposition of infusions of atracurium and its metabolite, laudanosine, in patients with renal and respiratory failure in an ITU. Br J Anaesth. 1988;61:531-540.
21. Segredo V, Matthay MA, Sharma ML, Gruenke LD, Caldwell JE, Miller RD. Prolonged neuromuscular blockade after long-term administration of vecuronium in two critically ill patients. Anesthesiology. 1990;72:566-570.
22. Slater RM, Pollard BJ, Doran BR. Prolonged neuromuscular blockade with vecuronium in renal failure. Anaesthesia. 1988;43:250-251.
23. Griffiths RB. Atracurium infusions in patients with renal failure on an ITU. Anaesthesia. 1986;41:375-381.
24. Fishman AP, ed. Pulmonary Diseases and Disorders. 2nd ed. New York, NY: McGraw-Hill International Book Co; 1988.
25. Shoemaker WC, Ayres S, Grenvik A, Holbrook PR, Thompson WL, eds. Textbook of Critical Care. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1989.
26. Bevan DR, Bevan JC, Donati F. Muscle Relaxants in Clinical Anesthesia. Chicago, Ill: Year Book Medical Publishers Inc; 1988.
27. Viby-Mogensen J. Clinical assessment of neuromuscular transmission. Br J Anaesth. 1982; 54:209-223.
28. Nagashima H, Nguyen HD, Conforti M, Duncalf D, Goldiner PL, Foldes FF. A simple method for monitoring muscular relaxation during continuous infusion of vecuronium. Can J Anaesth. 1988;35:134-138.
29. Beemer GH. Continuous infusions of muscle relaxants: why and how. Anaesth Intensive Care. 1987;15:83-89.
30. American Board of Internal Medicine. 1991 ABIM Examination in Critical Care Medicine. Portland, Ore: American Board of Internal Medicine; Spring-Summer, 1991. Newsletter.
31. Oldenhof H, de Jong M, Steenhoek A, Janknegt R. Clinical pharmacokinetics of midazolam in intensive care patients: a wide interpatient variability? Clin Pharmacol Ther. 1989;43:263-269.
32. Peat SJ, Potter DR, Hunter JM. The prolonged use of atracurium in a patient with tetanus. Anaesthesia. 1988;43:962-963.
33. Parker MM, Schubert W, Shelhamer JH, Parillo JE. Perceptions of a critically ill patient experiencing therapeutic paralysis in an ICU. Crit Care Med. 1984;12:69-71.
34. Durbin CG. Neuromuscular blocking agents and sedating drugs: clinical uses and toxic effects in the critical care unit. Crit Care Clin. 1991;7:489-506.